PROVENTIV THERAPEUTICS

proventiv-therapeutics-logo

Proventiv Therapeutics, L.L.C. develops and commercializes pharmaceutical products to treat and prevent the clinical consequences of diseases and disorders related to vitamin D deficiency.

#SimilarOrganizations #More

PROVENTIV THERAPEUTICS

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
2005-01-01

Address:
Fitchburg, Wisconsin, United States

Country:
United States

Status:
Active

Contact:
(608)239-0168


Similar Organizations

gemin-x-pharmaceuticals-logo

Gemin X Pharmaceuticals

Gemin X Pharmaceuticals develops and commercializes targeted cancer therapeutics to improve the lives of patients.

ichor-therapeutics-logo

Ichor Therapeutics

Ichor Therapeutics develops and commercializes research and clinical products in the field of regenerative medicine.

not_available_image

Secant Therapeutics

Secant Therapeutics develops a percutaneous transcatheter direct plication annuloplasty (DPA) device.

More informations about "Proventiv Therapeutics"

Proventive Therapeutics - PitchBook

Developer of proprietary products to treat and prevent the clinical consequences of diseases and disorders related to vitamin D deficiency. The company owns patent applications for vitamin D โ€ฆSee details»

Proventiv Therapeutics - Overview, News & Similar companies

Who is Proventiv Therapeutics. Proventiv Therapeutics LLC is a company that operates in the Biotechnology industry. It employs 6-10 people and has $1M-$5M of revenue. The company is โ€ฆSee details»

Cytochroma acquires Proventiv Therapeutics - 2006-06-29

Proventiv Therapeutics Proventiv Therapeutics develops and commercializes pharmaceutical products to treat and prevent the clinical consequences of diseases. Acquiring Organization: โ€ฆSee details»

Proventiv Therapeutics LLC - Company Profile and News

Company profile page for Proventiv Therapeutics LLC including stock price, company news, executives, board members, and contact informationSee details»

Proventiv Therapeutics - Crunchbase

Proventiv Therapeutics develops and commercializes pharmaceutical products to treat and prevent the clinical consequences of diseases.See details»

Proventiv Therapeutics LLC Company Profile, Financial and โ€ฆ

Proventiv Therapeutics, L.L.C. develops and commercializes pharmaceutical products to treat and prevent the clinical consequences of diseases and disorders related to vitamin D deficiency. It โ€ฆSee details»

Proventiv Therapeutics LLC:Company Profile & Technical Research ...

Proventiv Therapeutics LLC is headquartered in United States Wisconsin. Proventiv Therapeutics LLC was founded in 2005. Proventiv Therapeutics LLC has a total of 41 patents . Related โ€ฆSee details»

PROVENTIV THERAPEUTICS LLC innovation strategy - GoodIP

PROVENTIV THERAPEUTICS LLC has a total of 19 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2006. It filed its patents most often in โ€ฆSee details»

010855994 EIN/TAX ID | PROVENTIV THERAPEUTICS, LLC | ,

PROVENTIV THERAPEUTICS, LLC: Conformed submission company name, business name, organization name, etc CIK: N/S (NOT SPECIFIED) Company's Central Index Key (CIK). The โ€ฆSee details»

EX-2.10 - SEC.gov

PROVENTIV THERAPEUTICS, LLC . CYTOCHROMA CAYMAN ISLANDS, LTD., OPKO HEALTH, INC. and . OPKO IP HOLDINGS, INC. January 8, 2013 . TABLE OF CONTENTS . โ€ฆSee details»

PROVENTIV THERAPEUTICS, LLC Inventions, Patents ... - Justia โ€ฆ

Abstract: The method of treating elevated blood levels of iPTH by increasing or maintaining blood concentrations of both 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in a patient by โ€ฆSee details»

Patents Assigned to Proventiv Therapeutics, LLC - Justia Patents โ€ฆ

Patents Assigned to Proventiv Therapeutics, LLC Methods and compounds for vitamin D therapy. Patent number: 8592401 Abstract: Methods and compositions comprising 1,25 โ€ฆSee details»

What is Proventiv Therapeutics? Company Culture, Mission, Values

Proventiv Therapeutics. Is this your company? This employer has not claimed their Employer Profile and is missing out on connecting with our community. Connect with our community. โ€ฆSee details»

Cytochroma Inc. Acquires Proventiv Therapeutics To ... - BioSpace

Cytochroma Inc. Acquires Proventiv Therapeutics To ... - BioSpaceSee details»

Working at Proventiv Therapeutics - Glassdoor

See what employees say it's like to work at Proventiv Therapeutics. Salaries, reviews, and more - all posted by employees working at Proventiv Therapeutics.See details»

Effects of probiotics on gut microbiota: mechanisms of intestinal ...

Probiotics have been proposed as preventive and therapeutic measures, in order to restore the healthy composition and function of the gut microbiome. However, data from human โ€ฆSee details»

WHO preferred product characteristics for therapeutic HPV vaccines

Jul 3, 2024 Therapeutic vaccines for human papillomavirus (HPV) are currently in development and could be an important new tool in the fight against cervical cancer. Unlike existing โ€ฆSee details»

Biotherapeutic products - World Health Organization (WHO)

WHO published โ€˜Quality control of biologicals produced by recombinant DNA techniquesโ€™ in 1983 (Bulletin of the World Health Organization, 61). The article reviewed the application of โ€ฆSee details»

An orally bioavailable SARS-CoV-2 main protease inhibitor ... - AAAS

Mar 13, 2024 The toolkit for preventing and treating patients with COVID-19 has expanded greatly since the pandemic began. Some of the most effective therapeutics for COVID-19 and, โ€ฆSee details»

Marker Therapeutics Awarded $9.5 Million Grant from the Cancer ...

8 hours ago โ€œWe are pleased to receive $9.5 million from CPRIT to explore MT-601 in our Phase 1 study in patients with pancreatic cancer,โ€ said Juan Vera, M.D., President and CEO of โ€ฆSee details»

linkstock.net © 2022. All rights reserved